Page last updated: 2024-11-04

sevoflurane and Congenital Hypocupremia

sevoflurane has been researched along with Congenital Hypocupremia in 2 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"We conclude that in patients with Menkes disease scheduled for surgery intravenous access should be established before the induction of general anesthesia."1.36[Anesthetic management of Menkes disease infant with difficult vascular access]. ( Baba, H; Furutani, K; Hashimoto, T; Taneoka, M; Tobita, T; Yoshida, T, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passariello, M1
Almenrader, N1
Pietropaoli, P1
Yoshida, T1
Furutani, K1
Hashimoto, T1
Taneoka, M1
Tobita, T1
Baba, H1

Other Studies

2 other studies available for sevoflurane and Congenital Hypocupremia

ArticleYear
Anesthesia for a child with Menkes disease.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:12

    Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Fever; Gastrostomy; Humans; Infant; Male; Menkes Ki

2008
[Anesthetic management of Menkes disease infant with difficult vascular access].
    Masui. The Japanese journal of anesthesiology, 2010, Volume: 59, Issue:10

    Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Catheterization, Peripheral;

2010